CG Oncology, Inc. Common stock (CGON) Revenue Growth
CG Oncology, Inc. Common stock (CGON) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2025-12-31 | 254.70% |
How CGON compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| VSTM | Verastem Inc. | 209.14% |
| VTGN | Vistagen Therapeutics Inc. | 161.11% |
| ABEO | Abeona Therapeutics Inc. | 147.52% |
| ETON | Eton Pharmaceuticals Inc. | 104.94% |
| RGNX | REGENXBIO Inc. | 104.54% |
These are five companies in the same sector as CGON with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get CG Oncology, Inc. Common stock Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("CGON", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CGON | $74.67 | +0.46% | 0.28M |
| 3 | ||||
| 4 | ||||
| 5 |